Use of Digital Health Technology in Heart Failure and Diabetes: a Scoping Review.
Dania KallasNavroop SandhuChristina GandiloMary SchleicherLaura BanksMariam JabaraLuiz Alberto Cerqueira Batista FilhoTracey J F ColellaKim ConnellyVarinder Kaur RandhawaPublished in: Journal of cardiovascular translational research (2022)
Use of digital health technologies (DHT) in chronic disease management is rising. We aim to evaluate the impact of DHT on clinical outcomes from randomized controlled trials (RCTs) of patients with heart failure (HF) and diabetes mellitus (DM). Electronic databases were searched for DHT RCTs in patients with HF and DM until February 2021. Patient characteristics and outcomes were analyzed. One published (N = 519) and 6 registered (N = 3423) eligible studies were identified, with one study exclusively including HF and DM patients. Median DHT monitoring was 12 months, with six studies using mobile platforms as their key exposure. Clinical outcomes included quality-of-life or self-care surveys (n = 1 each), physical activity metrics, changes in biomarkers, and other clinical endpoints (n = 3). Limited data exist on RCTs evaluating DHT in patients with concomitant HF and DM. Further work should define standardized clinical endpoints and platforms that can manage patients with multiple comorbidities.
Keyphrases
- glycemic control
- heart failure
- physical activity
- public health
- acute heart failure
- healthcare
- randomized controlled trial
- type diabetes
- newly diagnosed
- body mass index
- big data
- prognostic factors
- end stage renal disease
- clinical trial
- metabolic syndrome
- atrial fibrillation
- case report
- adipose tissue
- risk assessment
- artificial intelligence
- deep learning
- social media
- meta analyses
- patient reported outcomes
- cardiac resynchronization therapy